CoChat

Hepatocellular Carcinoma Risk Prediction Model for the General Population: The Predictive Power of Transaminases

Open access
Wen, Chi-Pang, Lin, Jie, Yang, Yi Chen, Tsai, Min Kuang, Tsao, Chwen Keng, Etzel, Carol, Huang, Maosheng, Hsu, Chung Yi, Ye, Yuanqing, Mishra, Lopa, Hawk, Ernest, Wu, Xifeng · 2012 · JNCI: Journal of the National Cancer Institute
Cited by 120

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Risk prediction models for hepatocellular carcinoma are available for individuals with chronic hepatitis B virus (HBV) and hepatitis C virus (HCV) infections who are at high risk but not for the general population with average or unknown risk. We developed five simple risk prediction models based on clinically available data from the general population. METHODS: A prospective cohort of 428 584 subjects from a private health screening firm in Taiwan was divided into two subgroups-one with known HCV test results (n = 130 533 subjects) and the other without (n = 298 051 subjects). A total of 1668 incident hepatocellular carcinomas occurred during an average follow-up of 8.5 years. Model inputs included age, sex, health history-related variables; HBV or HCV infection-related variables; serum levels of alanine transaminase (ALT), aspartate transaminase (AST), and alfa-fetoprotein (AFP), as well as other variables of routine blood panels for liver function. Cox proportional hazards regression method was used to identify risk predictors of hepatocellular carcinoma. Receiver operating characteristic curves were used to assess discriminatory accuracy of the models. Models were internally validated. All statistical tests were two-sided. RESULTS: Age, sex, health history, HBV and HCV status, and serum ALT, AST, AFP levels were statistically significant independent predictors of hepatocellular carcinoma risk (all P < .05). Use of serum transaminases only in a model showed a higher discrimination compared with HBV or HCV only (for transaminases, area under the curve [AUC] = 0.912, 95% confidence interval [CI] = 0.909 to 0.915; for HBV, AUC = 0.840, 95% CI = 0.833 to 0.848; and for HCV, AUC = 0.841, 95% CI = 0.834 to 0.847). Adding HBV and HCV data to the transaminase-only model improved the discrimination (AUC = 0.933, 95% CI = 0.929 to 0.949). Internal validation showed high discriminatory accuracy and calibration of these models. CONCLUSION: Models with transaminase data were best able to predict hepatocellular carcinoma risk even among subjects with unknown or HBV- or HCV-negative infection status.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/jnci/djs372

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 120

Metadata

Authors
Wen, C.-P., Lin, J., Yang, Y. C., Tsai, M. K., Tsao, C. K., Etzel, C., Huang, M., Hsu, C. Y., Ye, Y., Mishra, L., Hawk, E., & Wu, X.
Venue
JNCI: Journal of the National Cancer Institute
Published
2012-10-16
Volume
104
Issue
20
Pages
1599-1611
ISSN
  • 0027-8874 (ISSN-L)
  • 1460-2105
OpenAlex
W2121906319
Cited by
120
References
4
FWCI
4.08
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Hepatocellular Carcinoma Risk Prediction Model for the General Population: The Predictive Power of Transaminases. https://app.cochat.ai/papers/10.1093/jnci/djs372
The paper
Wen, C.-P., Lin, J., Yang, Y. C., Tsai, M. K., Tsao, C. K., Etzel, C., Huang, M., Hsu, C. Y., Ye, Y., Mishra, L., Hawk, E., & Wu, X. (2012). Hepatocellular Carcinoma Risk Prediction Model for the General Population: The Predictive Power of Transaminases. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djs372

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.